z-logo
open-access-imgOpen Access
Undifferentiated connective tissue diseases-related hepatic injury
Author(s) -
Ying Zhang,
Fu-Kui Zhang,
Xiaoning Wu,
Tailing Wang,
Jidong Jia,
Bao-en Wang
Publication year - 2008
Publication title -
world journal of gastroenterology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.14.2780
Subject(s) - medicine , undifferentiated connective tissue disease , prednisone , connective tissue , erythrocyte sedimentation rate , gastroenterology , anti nuclear antibody , pathology , liver function tests , liver biopsy , liver injury , differential diagnosis , eosinophilia , biopsy , connective tissue disease , immunology , antibody , autoimmune disease , autoantibody , disease
Hepatic injury is rarely associated with undifferentiated connective tissue diseases (UCTD). We report, here, a case of a middle-aged woman with UCTD-related hepatic injury, including its case history, clinical manifestations, laboratory findings, treatment and its short-term effect. The patient was admitted to the hospital with symptoms of fatigue, anorexia, low-grade fever and skin rashes. She had a past history of left knee joint replacement. Laboratory tests showed elevated levels of serum transaminase, IgG and globulin, accelerated erythrocyte sedimentation rate, eosinophilia and a high titer of antinuclear antibodies (1:320). Imaging studies showed interstitial pneumonitis and hydropericardium. Liver biopsy showed the features which were consistent with those of connective tissue diseases-related polyangitis. After treatment with a low-dose of oral prednisone, both symptoms and laboratory findings were significantly improved. UCTD-related hepatic injury should be considered in the differential diagnosis of connective tissue diseases with abnormal liver function tests. Low-dose prednisone may effectively improve both symptoms and laboratory tests.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here